David H. Abramson

Systemic carboplatin for retinoblastoma: change in tumour size over time

D. Abramson, I. Dunkel, K. Beaverson, 2005, British Journal of Ophthalmology.

A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.

D. Abramson, I. Dunkel, C. M. Frank, 1999, Ophthalmology.

Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).

S. Brodie, Y. Gobin, I. Dunkel, 2010, Ophthalmology.

Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma

S. Brodie, Y. Gobin, D. Abramson, 2009, Documenta Ophthalmologica.

Trilateral retinoblastoma: Potentially curable with intensive chemotherapy

J. O'Brien, M. Souweidane, J. Finlay, 2010, Pediatric blood & cancer.

Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)

S. Brodie, A. Fabius, Y. Gobin, 2016, PloS one.

Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.

D. Abramson, C. M. Frank, David H. Abramson, 1998, Ophthalmology.